2021
Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors
Dunbar A, Bolton KL, Devlin SM, Sanchez-Vega F, Gao J, Mones JV, … Park W, …
Blood 137(15), 2103–2113
107Citations
2021Year
Related by topic
Publication · Genomics, BiomarkerMolecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancerPublication · GenomicsAlterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinomaPublication · GenomicsAutomated real-world data integration improves cancer outcome predictionResearch Program · GenomicsBiliary Tract CancerPublication · BiomarkerClinical implications of circulating tumor DNA tumor mutational burden (ctDNA TMB) in non-small cell lung cancerPublication · GenomicsClinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival
Local graph
Drag to pan · scroll to zoom · drag a node to move · double-click to open